Membranous nephropathy at a glance
Anti-PLA2R (most primary MN): diagnoses without biopsy, grades risk, shows when to stop.
- Pathogenesis Anti-PLA2R → subepithelial deposits → heavy proteinuria.
- Serological diagnosis PLA2R + nephrotic + normal eGFR: no biopsy.
- Immunological monitoring PLA2R clears before proteinuria.
-
Stop 1 · Assessment
Evaluation of nephrotic proteinuria
Quantify, then prove glomerular origin.
1Quantification
24h protein or uPCR, albumin, cholesterol, urine microscopy, eGFR.
2Glomerular origin
Albuminuria >3.5 g/day; urine albumin/total protein >0.5.
3UPEP pattern
Albumin band = glomerular; beta zone (β2-microglobulin, RBP) = tubular; monoclonal spike = overflow.
Differential diagnosis
MN, FSGS, minimal change disease, diabetic nephropathy, amyloidosis.
Rising creatinine (RPGN picture)
Urgent biopsy: superimposed crescents, AIN, renal vein thrombosis.
Exam trapNo haematuria ≠ not glomerular. Haematuria in only 30–50% of MN; red cell casts rare.
-
Stop 2 · Serology
Anti-PLA2R serology
Subscribers only
Unlock the other 6 stops
Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.
- Secondary causes
- Supportive therapy
- Risk stratification and immunosuppression
- Immunological response
- Relapse and treatment resistance